Zutectra
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Zutectra, covering 2015-03-25 to 2026-08-25. Get the full timeline:
Most recent: EMA Authorised: Zutectra (human hepatitis B immunoglobulin) — Biotest Pharma GmbH